Core Viewpoint - The recent policy document issued by the Ministry of Commerce and nine other departments aims to enhance the quality and functionality of the pharmaceutical retail industry in China, transforming drugstores into "health stations" that provide professional services, health promotion, and emergency supply capabilities [2][5]. Group 1: Industry Development - The pharmaceutical retail industry is a crucial part of China's healthcare system, with a growing network and increasing chain store levels, contributing positively to drug supply and accessibility for the public [2]. - The market size of China's pharmaceutical distribution has expanded, with annual sales increasing from 2.41 trillion yuan in 2020 to an expected 2.95 trillion yuan in 2024 [2]. Group 2: Policy Measures - The policy encourages the establishment of pharmaceutical service platforms by retail chain headquarters, allowing licensed pharmacists to provide remote prescription reviews and medication guidance [3]. - Retail pharmacies will be able to offer the same medical insurance reimbursement policies as grassroots medical institutions, enhancing accessibility for patients [3]. - The document promotes participation in centralized drug procurement to lower retail prices and encourages joint purchasing among pharmacies to improve bargaining power [3]. Group 3: Quality Improvement - The policy advocates for optimizing the application process for drug business licenses and encourages the sale of innovative drugs and reference preparations through retail channels to enhance supply quality [3]. - Support for mergers and acquisitions among retail pharmacies and the integration of wholesale and retail operations is encouraged to improve supply chain efficiency and promote fair competition [3]. Group 4: Emergency Services and Community Engagement - The policy emphasizes strengthening emergency services in retail pharmacies, encouraging large chains to establish dynamic demand forecasting and low inventory warning systems [3]. - Retail pharmacies are encouraged to provide care services for outdoor workers and collaborate with community organizations to offer health care services for the elderly, disabled, and children [4]. Group 5: Industry Fairness and Collaboration - The document stresses the importance of fair competition in the industry, advocating for deep cooperation between pharmaceutical manufacturers and large distribution companies to regulate drug pricing and maintain reasonable retail prices [4].
打造“健康驿站” 9部门发文促药品零售行业高质量发展
Xin Lang Cai Jing·2026-01-27 21:04